These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7770788)

  • 1. [Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group].
    Röttinger EM
    Strahlenther Onkol; 1995 May; 171(5):303-4. PubMed ID: 7770788
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.
    Geyer JR; Zeltzer PM; Boyett JM; Rorke LB; Stanley P; Albright AL; Wisoff JH; Milstein JM; Allen JC; Finlay JL
    J Clin Oncol; 1994 Aug; 12(8):1607-15. PubMed ID: 8040673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiotherapy and/or chemotherapy in children with primitive neuroectodermal tumor (PNET) of the pineal region].
    Dunst J
    Strahlenther Onkol; 1996 Feb; 172(2):108-9. PubMed ID: 8669042
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
    J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
    Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ototoxicity in children with malignant brain tumors treated with the "8 in 1" chemotherapy protocol.
    Ilveskoski I; Saarinen UM; Wiklund T; Perkkiö M; Salmi TT; Lanning M; Mäkipernaa A; Pihko H
    Med Pediatr Oncol; 1996 Jul; 27(1):26-31. PubMed ID: 8614387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of the "8 drugs in a day" protocol in brain tumors in children].
    Chastagner P; Olive D; Philip T; Zucker JM; Czorny A; Lapras C; Brunat-Mentigny M
    Arch Fr Pediatr; 1988 Apr; 45(4):249-54. PubMed ID: 3408307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of intensive chemotherapy in the treatment of medulloblastoma/primitive neuroectodermal tumor in children].
    Konoplia NE; Strongin IuS; Talabaev MV; Aleĭnikova OV
    Vopr Onkol; 2008; 54(2):157-63. PubMed ID: 18522163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination chemotherapy with MOPP and intrathecal methotrexate in children with brain tumors].
    Sato J; Ninomiya T; Saijo T; Akita H; Miki Y; Hirose M; Hashimoto T; Miyao M; Matsumoto K
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3266-70. PubMed ID: 3777962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience.
    Duffner PK; Horowitz ME; Krischer JP; Burger PC; Cohen ME; Sanford RA; Friedman HS; Kun LE
    Neuro Oncol; 1999 Apr; 1(2):152-61. PubMed ID: 11554387
    [No Abstract]   [Full Text] [Related]  

  • 13. Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
    Choi LM; Rood B; Kamani N; La Fond D; Packer RJ; Santi MR; Macdonald TJ
    Pediatr Blood Cancer; 2008 May; 50(5):970-5. PubMed ID: 17941070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors.
    Finlay JL
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S1-5. PubMed ID: 8971398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study.
    Evans AE; Anderson JR; Lefkowitz-Boudreaux IB; Finlay JL
    Med Pediatr Oncol; 1996 Jul; 27(1):8-14. PubMed ID: 8614396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the dosage of vincristine: a clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors.
    Kellie SJ; Koopmans P; Earl J; Nath C; Roebuck D; Uges DR; De Graaf SS
    Cancer; 2004 Jun; 100(12):2637-43. PubMed ID: 15197807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.
    Hong TS; Mehta MP; Boyett JM; Donahue B; Rorke LB; Zeltzer PM
    Pediatr Blood Cancer; 2005 Oct; 45(5):676-82. PubMed ID: 16007595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of primary brain tumors.
    Levin VA
    Neurol Clin; 1985 Nov; 3(4):855-66. PubMed ID: 3001491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
    Gill P; Litzow M; Buckner J; Arndt C; Moynihan T; Christianson T; Ansell S; Galanis E
    Cancer; 2008 Apr; 112(8):1805-11. PubMed ID: 18300237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.